A new study explores the reasons why tirzepatide, the once-weekly injection used to treat obesity and type 2 diabetes, is ...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...

Across all studies and doses, females lost up to 24.6% of body weight from baseline whereas men lost a maximum of 18.1% of ...

Can weight loss medications trigger a thyroid crisis? In this case, rapid weight loss from tirzepatide led to ...

Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have ...

ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body ...

The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also ...

Tirzepatide vs GLP-1 agonists demonstrated superior cardiorenal benefits among patients with type 2 diabetes. Treatment with tirzepatide, compared with glucagon-like peptide 1 (GLP-1) receptor ...